AKT1 and breast carcinoma: In addition, Apigenin administration increased the expression of forkhead box O3 (FOXO3)—a transcription factor with tumor-suppressing properties that is a downstream target of Akt—via the Akt/PI3K pathway, leading to apoptosis induction in human breast cancer cells [119].